Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021
February 09, 2021 15:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention...
Anika Reports Third-Quarter 2020 Financial Results
November 04, 2020 16:05 ET
|
Anika Therapeutics Inc.
Revenue Increased 7% Year-over-Year to $31.7 MillionRepaid $25 Million of Outstanding Credit FacilityContinued Expansion of Joint Preservation Product Portfolio BEDFORD, Mass., Nov. 04, 2020 (GLOBE...
Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020
October 22, 2020 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention...
Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints
October 21, 2020 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention...
Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors
September 08, 2020 16:53 ET
|
Anika Therapeutics Inc.
Board Chair Joseph Bower, D.B.A. announces intention not to stand for re-election at 2021 Annual MeetingJeffery Thompson succeeds Dr. Bower as Chair of the Board BEDFORD, Mass., Sept. 08, 2020 ...
Anika to Participate in Upcoming Virtual Investor Conferences
September 03, 2020 14:34 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
Anika Appoints Michael Levitz as Chief Financial Officer
August 05, 2020 16:09 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
Anika Reports Second Quarter 2020 Financial Results
July 30, 2020 16:05 ET
|
Anika Therapeutics Inc.
Increased Total Revenue 1% Year-over-Year to $30.7 MillionAccelerated the Commercial Integration of Parcus Medical and Arthrosurface OrganizationsLaunching Seven FDA-Cleared Orthopedic and Sports...
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
July 20, 2020 07:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
Anika to Issue Second Quarter 2020 Financial Results and Business Highlights on Thursday, July 30
July 16, 2020 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...